首站-论文投稿智能助手
典型文献
Efficacy of Acitretin Monotherapy on Basal Cell Carcinoma: A Case Report
文献摘要:
Introduction::Basal cell carcinoma (BCC) is the most common skin cancer which mainly affects the population over 50 years of age. In addition to surgical treatment, nonsurgical treatment is also an attractive option for some patients.Case presentation::An 82-year-old man presented with BCC on his left nose wing more than 2 years ago. Due to his unwillingness to accept treatment that may lead to pain, discomfort, or trauma, the patient was prescribed oral acitretin 25 mg twice daily [0.8 mg/(kg·d)] and was instructed to apply 2% fusidic acid cream topically once daily for trauma protection. The lesion progressively shrank in size after 4 weeks of treatment, and was almost completely resolved after 28 weeks of follow-up. The patient reported mild adverse effects, such as mild skin fragility and cheilitis, and apparent scaling skin, which caused minor discomfort but did not affect the continuation of treatment.Discussion::The pathogenesis of BCC is still unclear, but it has been demonstrated to be linked to overactive hedgehog signaling and its crosstalk with other pathways such as phosphoinositide 3-kinase and mammalian target of rapamycin. Acitretin could obviously inhibit cell growth and proliferation and down-regulate AMP-dependent protein kinases that plays critical role in the blocking of malignant progression of several tumors including BCC.Conclusion::We provide an effective alternative for the patients with BCC who are unwilling to receive surgical therapy.
文献关键词:
acitretin;monotherapy;basal cell carcinoma
作者姓名:
Chen Ping-Jiao;Liang Jing-Yao;Tian Xin;Li Chang-Xing;Zhang Xi-Bao
作者机构:
Department of Dermatology of Southern Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Institute of Dermatology, Guangzhou Medical University, Guangzhou, Guangdong 510095, China;Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, Guangdong 510095, China
引用格式:
[1]Chen Ping-Jiao;Liang Jing-Yao;Tian Xin;Li Chang-Xing;Zhang Xi-Bao-.Efficacy of Acitretin Monotherapy on Basal Cell Carcinoma: A Case Report)[J].国际皮肤性病学杂志(英文),2022(03):172-174
A类:
Acitretin,Monotherapy,acitretin,instructed,fusidic,cheilitis
B类:
Efficacy,Basal,Cell,Carcinoma,Case,Report,Introduction,cell,carcinoma,BCC,common,skin,cancer,which,mainly,affects,population,years,age,addition,treatment,nonsurgical,also,attractive,option,some,patients,presentation,An,old,man,presented,his,left,nose,wing,more,than,ago,Due,unwillingness,accept,that,may,lead,pain,discomfort,trauma,was,prescribed,oral,twice,daily,apply,acid,cream,topically,once,protection,lesion,progressively,shrank,size,after,weeks,almost,completely,resolved,follow,up,reported,mild,adverse,effects,such,fragility,apparent,scaling,caused,minor,but,did,continuation,Discussion,pathogenesis,still,unclear,has,been,demonstrated,linked,overactive,hedgehog,signaling,its,crosstalk,pathways,phosphoinositide,mammalian,target,rapamycin,could,obviously,inhibit,growth,proliferation,down,regulate,AMP,dependent,protein,kinases,plays,critical,role,blocking,malignant,progression,several,tumors,including,Conclusion,We,provide,effective,alternative,who,receive,monotherapy,basal
AB值:
0.612956
相似文献
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Wei Tang;Yu Wu;Xin Qi;Rilei Yu;Zhimin Lu;Ao Chen;Xinglong Fan;Jing Li-Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China;Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China;Department of Thoracic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao 266003, China;Open Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao 266003, China;Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。